Unknown

Dataset Information

0

Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.


ABSTRACT:

Introduction

Although human papillomavirus (HPV) routine vaccination programmes have been implemented around the world and recommendations have been expanded to include other high-risk individuals, current recommendations often differ between countries in Europe, as well as worldwide.

Aim

To find and summarise the best available evidence of HPV vaccination in high-risk patients aiding clinicians and public health workers in the day-to-day vaccine decisions relating to HPV in Spain.

Methods

We conducted a systematic review of the immunogenicity, safety and efficacy/effectiveness of HPV vaccination in high-risk populations between January 2006 and June 2016. HPV vaccination recommendations were established with levels of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.

Results

A strong recommendation about HPV vaccination was made in the following groups: HIV infected patients aged 9-26 years; men who have sex with men aged 9-26 years; women with precancerous cervical lesions; patients with congenital bone marrow failure syndrome; women who have received a solid organ transplant or hematopoietic stem cell transplantation aged 9-26 years; and patients diagnosed with recurrent respiratory papillomatosis.

Conclusions

Data concerning non-routine HPV vaccination in populations with a high risk of HPV infection and associated lesions were scarce. We have developed a document to evaluate and establish evidence-based guidelines on HPV vaccination in high-risk populations in Spain, based on best available scientific evidence.

SUBMITTER: Martinez-Gomez X 

PROVIDER: S-EPMC6381660 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.

Martínez-Gómez Xavier X   Curran Adrian A   Campins Magda M   Alemany Laia L   Rodrigo-Pendás José Ángel JÁ   Borruel Natalia N   Castellsagué Xavier X   Díaz-de-Heredia Cristina C   Moraga-Llop Fernando A FA   Del Pino Marta M   Torné Aureli A  

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20190201 7


<h4>Introduction</h4>Although human papillomavirus (HPV) routine vaccination programmes have been implemented around the world and recommendations have been expanded to include other high-risk individuals, current recommendations often differ between countries in Europe, as well as worldwide.<h4>Aim</h4>To find and summarise the best available evidence of HPV vaccination in high-risk patients aiding clinicians and public health workers in the day-to-day vaccine decisions relating to HPV in Spain  ...[more]

Similar Datasets

| S-EPMC8771805 | biostudies-literature
| S-EPMC8576825 | biostudies-literature
| S-EPMC9611461 | biostudies-literature
| S-EPMC3884730 | biostudies-literature
| S-EPMC7797127 | biostudies-literature
| S-EPMC5645176 | biostudies-literature
| S-EPMC3495774 | biostudies-literature
| S-EPMC7689747 | biostudies-literature
| S-EPMC5708664 | biostudies-literature
| S-EPMC5545972 | biostudies-literature